Literature DB >> 8626560

Intracellular polymerization of the serpin plasminogen activator inhibitor type 2.

P Mikus1, T Ny.   

Abstract

Plasminogen activator inhibitor type 2 (PAI-2) is synthesized in two molecular forms: an intracellular, nonglycosylated form and an extracellular, glycosylated form. The bitopological distribution of PAI-2 is caused by an inefficient internal secretion signal. In addition, the secretion efficiency of PAI-2 seems to differ, depending on the cell type, differentiation state, and culture conditions. In recombinant cell clones designed for the synthesis of the secreted form of PAI-2, the fraction of secreted PAI-2 decreased with increasing expression levels. Subcellular fractionation of cell clones with higher expression levels revealed that PAI-2 accumulating in the cell was mainly associated with the organelles of the secretory pathway. Electrophoresis under nondenaturating conditions revealed that the PAI-2 retained at higher expression levels was mainly polymerized. Polymers of PAI-2 were also detected in cytosolic extracts prepared from human placenta and phorbol ester-stimulated U 937 cells, indicating that intracellular polymerization of PAI-2 may occur in the cytosols of cells that normally express PAI-2 under physiological conditions. When purified PAI-2 or cellular extracts were incubated at 37 degrees C for 24 h most of the PAI-2 protein was found to polymerize. Polymer formation was prevented by the addition of synthetic peptides with sequences corresponding to residues P2 to P14 in the reactive center loop of PAI-2 and antithrombin. These synthetic peptides also caused dissociation of prepolymerized purified PAI-2 and PAI-2 polymers in cellular extracts. Incubation with unrelated peptides of the same size had no effect on polymer formation or dissociation of preformed polymers, indicating that polymerization of PAI-2 occurs by the loop-sheet mechanism. Taken together, our data suggest that the wild-type form of PAI-2, like some natural pathological genetic variants of alpha1-antitrypsin, antithrombin, and C1 inhibitor readily polymerizes intracellularly and that polymerization may lead to a reduced secretion efficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626560     DOI: 10.1074/jbc.271.17.10048

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Mutagenesis of the bovSERPINA3-3 demonstrates the requirement of aspartate-371 for intermolecular interaction and formation of dimers.

Authors:  X Blanchet; A Péré-Brissaud; N Duprat; E Pinault; D Delourme; A Ouali; C Combet; A Maftah; P Pélissier; L Brémaud
Journal:  Protein Sci       Date:  2012-05-18       Impact factor: 6.725

2.  Serpin alpha 1proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy.

Authors:  H Koloczek; A Banbula; G S Salvesen; J Potempa
Journal:  Protein Sci       Date:  1996-11       Impact factor: 6.725

3.  The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival.

Authors:  K M Dougherty; J M Pearson; A Y Yang; R J Westrick; M S Baker; D Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization.

Authors:  Malgorzata Wilczynska; Sergei Lobov; Per-Ingvar Ohlsson; Tor Ny
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

Review 5.  Maspin: the new frontier.

Authors:  Zhila Khalkhali-Ellis
Journal:  Clin Cancer Res       Date:  2006-12-15       Impact factor: 12.531

6.  Maspin (SERPINB5) is an obligate intracellular serpin.

Authors:  Sonia S Y Teoh; James C Whisstock; Phillip I Bird
Journal:  J Biol Chem       Date:  2010-02-01       Impact factor: 5.157

7.  The human serpin proteinase inhibitor-9 self-associates at physiological temperatures.

Authors:  Lauren N Benning; James C Whisstock; Jiuru Sun; Phillip I Bird; Stephen P Bottomley
Journal:  Protein Sci       Date:  2004-07       Impact factor: 6.725

8.  Analysis of complement deposition and viral RNA in placentas of COVID-19 patients.

Authors:  J Justin Mulvey; Cynthia M Magro; Lucy X Ma; Gerard J Nuovo; Rebecca N Baergen
Journal:  Ann Diagn Pathol       Date:  2020-04-25       Impact factor: 2.090

9.  The CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activity.

Authors:  Blake J Cochran; Lakshitha P Gunawardhana; Kara L Vine; Jodi A Lee; Sergei Lobov; Marie Ranson
Journal:  BMC Biotechnol       Date:  2009-05-14       Impact factor: 2.563

10.  Deficiency of plasminogen activator inhibitor-2 results in accelerated tumor growth.

Authors:  Randal J Westrick; Lisa Payne Røjkjaer; Angela Y Yang; Michael H Roh; Amy E Siebert; David Ginsburg
Journal:  J Thromb Haemost       Date:  2020-10-01       Impact factor: 16.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.